Telesis Bio Inc. (TBIO) Operating Income (Loss) USD 2020 - 2024

Historical data

Taxonomy & unit: us-gaap: USD and USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Telesis Bio Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2024.
Telesis Bio Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$8.52 M, a 22.3% increase year-over-year.
Telesis Bio Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$44.1 M, a 1.13% increase year-over-year.
Telesis Bio Inc. annual Operating Income (Loss) for 2023 was -$46.5 M, a 0.12% decline from 2022.
Telesis Bio Inc. annual Operating Income (Loss) for 2022 was -$46.5 M, a 31.4% decline from 2021.
Telesis Bio Inc. annual Operating Income (Loss) for 2021 was -$35.4 M, a 116% decline from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly Data (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q1 2024	-$44.1 M	-$8.52 M	+$2.45 M	+22.3%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-10
Q4 2023	-$46.5 M	-$17.5 M	-$9.6 M	-122%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-29
Q3 2023	-$36.9 M	-$10.1 M	+$1.13 M	+10%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-13
Q2 2023	-$38.1 M	-$7.97 M	+$6.52 M	+45%	Apr 1, 2023	Jun 30, 2023	10-Q	2023-08-11
Q1 2023	-$44.6 M	-$11 M	+$1.89 M	+14.7%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-10
Q4 2022	-$46.5 M	-$7.88 M	+$4.21 M	+34.8%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-29
Q3 2022	-$50.7 M	-$11.3 M	-$1.81 M	-19.2%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-13
Q2 2022	-$48.9 M	-$14.5 M	-$6.92 M	-91.3%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-11
Q1 2022	-$42 M	-$12.9 M	-$6.6 M	-105%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-12
Q4 2021	-$35.4 M	-$12.1 M			Oct 1, 2021	Dec 31, 2021	10-K	2023-03-22
Q3 2021		-$9.44 M	-$5.14 M	-120%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-09
Q2 2021		-$7.57 M	-$4.28 M	-130%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-10
Q1 2021		-$6.26 M			Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-11
Q3 2020		-$4.3 M			Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-10
Q2 2020		-$3.3 M			Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-11

* An asterisk sign (*) next to the value indicates that the value is likely invalid.